nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—SLC22A4—ulcerative colitis	0.414	0.834	CbGaD
Levofloxacin—SLC22A4—Nicotine—ulcerative colitis	0.106	0.329	CbGbCtD
Levofloxacin—ABCB1—ulcerative colitis	0.0824	0.166	CbGaD
Levofloxacin—SLC22A2—Nicotine—ulcerative colitis	0.0573	0.177	CbGbCtD
Levofloxacin—CYP3A4—Budesonide—ulcerative colitis	0.021	0.0648	CbGbCtD
Levofloxacin—CYP1A2—Nicotine—ulcerative colitis	0.0174	0.0539	CbGbCtD
Levofloxacin—ABCB1—Methylprednisolone—ulcerative colitis	0.0157	0.0483	CbGbCtD
Levofloxacin—ABCB1—Betamethasone—ulcerative colitis	0.0102	0.0314	CbGbCtD
Levofloxacin—ABCB1—Prednisolone—ulcerative colitis	0.01	0.031	CbGbCtD
Levofloxacin—ABCB1—Hydrocortisone—ulcerative colitis	0.00952	0.0294	CbGbCtD
Levofloxacin—ABCB1—Prednisone—ulcerative colitis	0.00949	0.0293	CbGbCtD
Levofloxacin—CYP3A4—Methylprednisolone—ulcerative colitis	0.00938	0.029	CbGbCtD
Levofloxacin—CYP3A4—Nicotine—ulcerative colitis	0.00914	0.0282	CbGbCtD
Levofloxacin—CYP3A4—Cholecalciferol—ulcerative colitis	0.0082	0.0253	CbGbCtD
Levofloxacin—CYP3A4—Triamcinolone—ulcerative colitis	0.00711	0.0219	CbGbCtD
Levofloxacin—CYP3A4—Betamethasone—ulcerative colitis	0.0061	0.0188	CbGbCtD
Levofloxacin—CYP3A4—Prednisolone—ulcerative colitis	0.00602	0.0186	CbGbCtD
Levofloxacin—ABCB1—Dexamethasone—ulcerative colitis	0.00592	0.0183	CbGbCtD
Levofloxacin—CYP3A4—Hydrocortisone—ulcerative colitis	0.0057	0.0176	CbGbCtD
Levofloxacin—CYP3A4—Prednisone—ulcerative colitis	0.00568	0.0175	CbGbCtD
Levofloxacin—SLC22A4—Organic cation transport—SLC22A5—ulcerative colitis	0.00391	0.137	CbGpPWpGaD
Levofloxacin—CYP3A4—Dexamethasone—ulcerative colitis	0.00355	0.011	CbGbCtD
Levofloxacin—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A5—ulcerative colitis	0.00265	0.093	CbGpPWpGaD
Levofloxacin—SLC22A2—Organic cation transport—SLC22A5—ulcerative colitis	0.00185	0.0649	CbGpPWpGaD
Levofloxacin—SLC22A2—Organic cation transport—SLC22A4—ulcerative colitis	0.00185	0.0649	CbGpPWpGaD
Levofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—ulcerative colitis	0.0015	0.0528	CbGpPWpGaD
Levofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—ulcerative colitis	0.0015	0.0528	CbGpPWpGaD
Levofloxacin—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A4—ulcerative colitis	0.00125	0.044	CbGpPWpGaD
Levofloxacin—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—ulcerative colitis	0.00125	0.044	CbGpPWpGaD
Levofloxacin—SLC22A2—Abacavir transmembrane transport—ABCB1—ulcerative colitis	0.000964	0.0339	CbGpPWpGaD
Levofloxacin—Sparfloxacin—SLC22A5—ulcerative colitis	0.000752	0.204	CrCbGaD
Levofloxacin—Ofloxacin—SLC22A4—ulcerative colitis	0.000704	0.191	CrCbGaD
Levofloxacin—Lomefloxacin—SLC22A5—ulcerative colitis	0.000619	0.168	CrCbGaD
Levofloxacin—TOP2A—Methyldopa—Mesalazine—ulcerative colitis	0.000554	0.421	CbGdCrCtD
Levofloxacin—SLC22A2—Abacavir transport and metabolism—ABCB1—ulcerative colitis	0.000554	0.0195	CbGpPWpGaD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.000531	0.0186	CbGpPWpGaD
Levofloxacin—Ofloxacin—SLC22A5—ulcerative colitis	0.000529	0.144	CrCbGaD
Levofloxacin—Norfloxacin—SLC22A5—ulcerative colitis	0.000429	0.116	CrCbGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000409	0.0144	CbGpPWpGaD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.00033	0.0116	CbGpPWpGaD
Levofloxacin—Gatifloxacin—ALB—ulcerative colitis	0.00032	0.0867	CrCbGaD
Levofloxacin—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000308	0.0108	CbGpPWpGaD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.000301	0.0106	CbGpPWpGaD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.000301	0.0106	CbGpPWpGaD
Levofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—ulcerative colitis	0.000266	0.00934	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000265	0.0093	CbGpPWpGaD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.000251	0.00882	CbGpPWpGaD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.000251	0.00882	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000241	0.00847	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000232	0.00815	CbGpPWpGaD
Levofloxacin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000223	0.00783	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000208	0.0073	CbGpPWpGaD
Levofloxacin—Sparfloxacin—ABCB1—ulcerative colitis	0.000199	0.054	CrCbGaD
Levofloxacin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000198	0.00694	CbGpPWpGaD
Levofloxacin—TOP2A—Methyltestosterone—Hydrocortisone—ulcerative colitis	0.000197	0.15	CbGdCrCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000193	0.0068	CbGpPWpGaD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.000187	0.00659	CbGpPWpGaD
Levofloxacin—TOP2A—Methyltestosterone—Prednisone—ulcerative colitis	0.00017	0.129	CbGdCrCtD
Levofloxacin—TOP2A—Methyltestosterone—Prednisolone—ulcerative colitis	0.000166	0.126	CbGdCrCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CEP72—ulcerative colitis	0.000159	0.00559	CbGpPWpGaD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.000156	0.00549	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.00015	0.00528	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CEP72—ulcerative colitis	0.000142	0.00499	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000139	0.00489	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000137	0.00481	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000137	0.00481	CbGpPWpGaD
Levofloxacin—Ciprofloxacin—ABCB1—ulcerative colitis	0.000135	0.0367	CrCbGaD
Levofloxacin—TOP2A—Norethindrone—Hydrocortisone—ulcerative colitis	0.000128	0.0975	CbGdCrCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000123	0.0043	CbGpPWpGaD
Levofloxacin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000122	0.00428	CbGpPWpGaD
Levofloxacin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000122	0.00428	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—TP53—ulcerative colitis	0.000121	0.00425	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000118	0.00414	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000114	0.00401	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000114	0.00401	CbGpPWpGaD
Levofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000113	0.00399	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—GHRL—ulcerative colitis	0.000111	0.00389	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000107	0.00376	CbGpPWpGaD
Levofloxacin—TOP2A—Levonorgestrel—Hydrocortisone—ulcerative colitis	0.000102	0.0776	CbGdCrCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	9.83e-05	0.00345	CbGpPWpGaD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	9.52e-05	0.00334	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	9.46e-05	0.00332	CbGpPWpGaD
Levofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	9.07e-05	0.00319	CbGpPWpGaD
Levofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	9.06e-05	0.00318	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	8.72e-05	0.00306	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	8.68e-05	0.00305	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	8.52e-05	0.00299	CbGpPWpGaD
Levofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	8.36e-05	0.00294	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	8.27e-05	0.00291	CbGpPWpGaD
Levofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.91e-05	0.00278	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	7.69e-05	0.0027	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	7.63e-05	0.00268	CbGpPWpGaD
Levofloxacin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	7.35e-05	0.00258	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	7.23e-05	0.00254	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	7.1e-05	0.00249	CbGpPWpGaD
Levofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	7e-05	0.00246	CbGpPWpGaD
Levofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	6.99e-05	0.00246	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	6.95e-05	0.00244	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	6.95e-05	0.00244	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.67e-05	0.00234	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—CALM3—ulcerative colitis	6.48e-05	0.00228	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	6.36e-05	0.00224	CbGpPWpGaD
Levofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.31e-05	0.00222	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—PPARG—ulcerative colitis	5.8e-05	0.00204	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	5.79e-05	0.00204	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	5.79e-05	0.00204	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL10—ulcerative colitis	5.62e-05	0.00197	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—ALB—ulcerative colitis	5.41e-05	0.0019	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	5.37e-05	0.00189	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ulcerative colitis	5.3e-05	0.00186	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	5.15e-05	0.00181	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—CALM3—ulcerative colitis	4.97e-05	0.00175	CbGpPWpGaD
Levofloxacin—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	4.9e-05	0.00172	CbGpPWpGaD
Levofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	4.87e-05	0.00171	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	4.75e-05	0.00167	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	4.7e-05	0.00165	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	4.58e-05	0.00161	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	4.53e-05	0.00159	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4.39e-05	0.00154	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.33e-05	0.00152	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	4.12e-05	0.00145	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.1e-05	0.00144	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	4.07e-05	0.00143	CbGpPWpGaD
Levofloxacin—Nervous system disorder—Hydrocortisone—ulcerative colitis	4.04e-05	0.000277	CcSEcCtD
Levofloxacin—Myalgia—Methylprednisolone—ulcerative colitis	4.03e-05	0.000276	CcSEcCtD
Levofloxacin—Arthralgia—Methylprednisolone—ulcerative colitis	4.03e-05	0.000276	CcSEcCtD
Levofloxacin—Eye disorder—Prednisone—ulcerative colitis	4.03e-05	0.000276	CcSEcCtD
Levofloxacin—Anxiety—Methylprednisolone—ulcerative colitis	4.02e-05	0.000275	CcSEcCtD
Levofloxacin—Tachycardia—Hydrocortisone—ulcerative colitis	4.02e-05	0.000275	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	4.01e-05	0.00141	CbGpPWpGaD
Levofloxacin—Rash—Azathioprine—ulcerative colitis	4.01e-05	0.000274	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	4.01e-05	0.000274	CcSEcCtD
Levofloxacin—Dermatitis—Azathioprine—ulcerative colitis	4e-05	0.000274	CcSEcCtD
Levofloxacin—Flushing—Prednisone—ulcerative colitis	4e-05	0.000274	CcSEcCtD
Levofloxacin—Skin disorder—Hydrocortisone—ulcerative colitis	4e-05	0.000274	CcSEcCtD
Levofloxacin—Ill-defined disorder—Dexamethasone—ulcerative colitis	4e-05	0.000274	CcSEcCtD
Levofloxacin—Ill-defined disorder—Betamethasone—ulcerative colitis	4e-05	0.000274	CcSEcCtD
Levofloxacin—Discomfort—Triamcinolone—ulcerative colitis	3.99e-05	0.000274	CcSEcCtD
Levofloxacin—Discomfort—Methylprednisolone—ulcerative colitis	3.98e-05	0.000273	CcSEcCtD
Levofloxacin—Headache—Azathioprine—ulcerative colitis	3.98e-05	0.000273	CcSEcCtD
Levofloxacin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	3.98e-05	0.000273	CcSEcCtD
Levofloxacin—Diarrhoea—Mesalazine—ulcerative colitis	3.96e-05	0.000271	CcSEcCtD
Levofloxacin—Dry mouth—Triamcinolone—ulcerative colitis	3.95e-05	0.000271	CcSEcCtD
Levofloxacin—Angioedema—Dexamethasone—ulcerative colitis	3.94e-05	0.00027	CcSEcCtD
Levofloxacin—Angioedema—Betamethasone—ulcerative colitis	3.94e-05	0.00027	CcSEcCtD
Levofloxacin—Anorexia—Hydrocortisone—ulcerative colitis	3.92e-05	0.000269	CcSEcCtD
Levofloxacin—Angiopathy—Prednisone—ulcerative colitis	3.91e-05	0.000268	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	3.9e-05	0.00137	CbGpPWpGaD
Levofloxacin—Confusional state—Methylprednisolone—ulcerative colitis	3.9e-05	0.000267	CcSEcCtD
Levofloxacin—Immune system disorder—Prednisone—ulcerative colitis	3.89e-05	0.000267	CcSEcCtD
Levofloxacin—Malaise—Dexamethasone—ulcerative colitis	3.88e-05	0.000266	CcSEcCtD
Levofloxacin—Malaise—Betamethasone—ulcerative colitis	3.88e-05	0.000266	CcSEcCtD
Levofloxacin—Anaphylactic shock—Triamcinolone—ulcerative colitis	3.87e-05	0.000266	CcSEcCtD
Levofloxacin—Oedema—Triamcinolone—ulcerative colitis	3.87e-05	0.000266	CcSEcCtD
Levofloxacin—Vertigo—Dexamethasone—ulcerative colitis	3.87e-05	0.000265	CcSEcCtD
Levofloxacin—Vertigo—Betamethasone—ulcerative colitis	3.87e-05	0.000265	CcSEcCtD
Levofloxacin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	3.87e-05	0.000265	CcSEcCtD
Levofloxacin—Syncope—Betamethasone—ulcerative colitis	3.86e-05	0.000265	CcSEcCtD
Levofloxacin—Syncope—Dexamethasone—ulcerative colitis	3.86e-05	0.000265	CcSEcCtD
Levofloxacin—Arrhythmia—Prednisone—ulcerative colitis	3.85e-05	0.000264	CcSEcCtD
Levofloxacin—Infection—Triamcinolone—ulcerative colitis	3.85e-05	0.000264	CcSEcCtD
Levofloxacin—Hypotension—Hydrocortisone—ulcerative colitis	3.85e-05	0.000263	CcSEcCtD
Levofloxacin—Infection—Methylprednisolone—ulcerative colitis	3.84e-05	0.000263	CcSEcCtD
Levofloxacin—Dizziness—Mesalazine—ulcerative colitis	3.83e-05	0.000262	CcSEcCtD
Levofloxacin—Shock—Triamcinolone—ulcerative colitis	3.81e-05	0.000261	CcSEcCtD
Levofloxacin—Insomnia—Prednisolone—ulcerative colitis	3.81e-05	0.000261	CcSEcCtD
Levofloxacin—Alopecia—Prednisone—ulcerative colitis	3.81e-05	0.000261	CcSEcCtD
Levofloxacin—Shock—Methylprednisolone—ulcerative colitis	3.8e-05	0.000261	CcSEcCtD
Levofloxacin—Nervous system disorder—Methylprednisolone—ulcerative colitis	3.79e-05	0.00026	CcSEcCtD
Levofloxacin—Loss of consciousness—Dexamethasone—ulcerative colitis	3.79e-05	0.000259	CcSEcCtD
Levofloxacin—Loss of consciousness—Betamethasone—ulcerative colitis	3.79e-05	0.000259	CcSEcCtD
Levofloxacin—Paraesthesia—Prednisolone—ulcerative colitis	3.78e-05	0.000259	CcSEcCtD
Levofloxacin—Tachycardia—Triamcinolone—ulcerative colitis	3.78e-05	0.000259	CcSEcCtD
Levofloxacin—Mental disorder—Prednisone—ulcerative colitis	3.78e-05	0.000259	CcSEcCtD
Levofloxacin—Nausea—Azathioprine—ulcerative colitis	3.77e-05	0.000259	CcSEcCtD
Levofloxacin—Tachycardia—Methylprednisolone—ulcerative colitis	3.77e-05	0.000259	CcSEcCtD
Levofloxacin—Skin disorder—Methylprednisolone—ulcerative colitis	3.76e-05	0.000257	CcSEcCtD
Levofloxacin—Malnutrition—Prednisone—ulcerative colitis	3.75e-05	0.000257	CcSEcCtD
Levofloxacin—Erythema—Prednisone—ulcerative colitis	3.75e-05	0.000257	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	3.75e-05	0.000257	CcSEcCtD
Levofloxacin—Hyperhidrosis—Triamcinolone—ulcerative colitis	3.75e-05	0.000257	CcSEcCtD
Levofloxacin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	3.74e-05	0.000256	CcSEcCtD
Levofloxacin—Insomnia—Hydrocortisone—ulcerative colitis	3.72e-05	0.000255	CcSEcCtD
Levofloxacin—Hypertension—Dexamethasone—ulcerative colitis	3.72e-05	0.000255	CcSEcCtD
Levofloxacin—Hypertension—Betamethasone—ulcerative colitis	3.72e-05	0.000255	CcSEcCtD
Levofloxacin—Paraesthesia—Hydrocortisone—ulcerative colitis	3.7e-05	0.000253	CcSEcCtD
Levofloxacin—Vomiting—Mesalazine—ulcerative colitis	3.68e-05	0.000252	CcSEcCtD
Levofloxacin—Myalgia—Betamethasone—ulcerative colitis	3.67e-05	0.000251	CcSEcCtD
Levofloxacin—Myalgia—Dexamethasone—ulcerative colitis	3.67e-05	0.000251	CcSEcCtD
Levofloxacin—Anxiety—Dexamethasone—ulcerative colitis	3.65e-05	0.00025	CcSEcCtD
Levofloxacin—Anxiety—Betamethasone—ulcerative colitis	3.65e-05	0.00025	CcSEcCtD
Levofloxacin—Rash—Mesalazine—ulcerative colitis	3.65e-05	0.00025	CcSEcCtD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.65e-05	0.00128	CbGpPWpGaD
Levofloxacin—Dermatitis—Mesalazine—ulcerative colitis	3.65e-05	0.00025	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	3.63e-05	0.00127	CbGpPWpGaD
Levofloxacin—Headache—Mesalazine—ulcerative colitis	3.63e-05	0.000248	CcSEcCtD
Levofloxacin—Discomfort—Dexamethasone—ulcerative colitis	3.62e-05	0.000248	CcSEcCtD
Levofloxacin—Discomfort—Betamethasone—ulcerative colitis	3.62e-05	0.000248	CcSEcCtD
Levofloxacin—Dyspepsia—Hydrocortisone—ulcerative colitis	3.62e-05	0.000248	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	3.61e-05	0.00127	CbGpPWpGaD
Levofloxacin—Hypotension—Methylprednisolone—ulcerative colitis	3.61e-05	0.000248	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.61e-05	0.00127	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—ADCY5—ulcerative colitis	3.6e-05	0.00127	CbGpPWpGaD
Levofloxacin—Pain—Prednisolone—ulcerative colitis	3.6e-05	0.000247	CcSEcCtD
Levofloxacin—Decreased appetite—Hydrocortisone—ulcerative colitis	3.58e-05	0.000245	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	3.55e-05	0.000243	CcSEcCtD
Levofloxacin—Fatigue—Hydrocortisone—ulcerative colitis	3.55e-05	0.000243	CcSEcCtD
Levofloxacin—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	3.54e-05	0.00124	CbGpPWpGaD
Levofloxacin—Vision blurred—Prednisone—ulcerative colitis	3.54e-05	0.000242	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	3.53e-05	0.000242	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	3.52e-05	0.000241	CcSEcCtD
Levofloxacin—Pain—Hydrocortisone—ulcerative colitis	3.52e-05	0.000241	CcSEcCtD
Levofloxacin—Anaphylactic shock—Dexamethasone—ulcerative colitis	3.52e-05	0.000241	CcSEcCtD
Levofloxacin—Anaphylactic shock—Betamethasone—ulcerative colitis	3.52e-05	0.000241	CcSEcCtD
Levofloxacin—Oedema—Betamethasone—ulcerative colitis	3.52e-05	0.000241	CcSEcCtD
Levofloxacin—Oedema—Dexamethasone—ulcerative colitis	3.52e-05	0.000241	CcSEcCtD
Levofloxacin—Insomnia—Triamcinolone—ulcerative colitis	3.5e-05	0.00024	CcSEcCtD
Levofloxacin—Insomnia—Methylprednisolone—ulcerative colitis	3.5e-05	0.00024	CcSEcCtD
Levofloxacin—Infection—Betamethasone—ulcerative colitis	3.49e-05	0.000239	CcSEcCtD
Levofloxacin—Infection—Dexamethasone—ulcerative colitis	3.49e-05	0.000239	CcSEcCtD
Levofloxacin—Ill-defined disorder—Prednisone—ulcerative colitis	3.48e-05	0.000239	CcSEcCtD
Levofloxacin—Paraesthesia—Triamcinolone—ulcerative colitis	3.48e-05	0.000238	CcSEcCtD
Levofloxacin—Feeling abnormal—Prednisolone—ulcerative colitis	3.47e-05	0.000238	CcSEcCtD
Levofloxacin—Paraesthesia—Methylprednisolone—ulcerative colitis	3.47e-05	0.000238	CcSEcCtD
Levofloxacin—Anaemia—Prednisone—ulcerative colitis	3.47e-05	0.000238	CcSEcCtD
Levofloxacin—Shock—Betamethasone—ulcerative colitis	3.46e-05	0.000237	CcSEcCtD
Levofloxacin—Shock—Dexamethasone—ulcerative colitis	3.46e-05	0.000237	CcSEcCtD
Levofloxacin—Dyspnoea—Triamcinolone—ulcerative colitis	3.45e-05	0.000237	CcSEcCtD
Levofloxacin—Nervous system disorder—Betamethasone—ulcerative colitis	3.45e-05	0.000236	CcSEcCtD
Levofloxacin—Nervous system disorder—Dexamethasone—ulcerative colitis	3.45e-05	0.000236	CcSEcCtD
Levofloxacin—Agitation—Prednisone—ulcerative colitis	3.45e-05	0.000236	CcSEcCtD
Levofloxacin—Thrombocytopenia—Dexamethasone—ulcerative colitis	3.44e-05	0.000236	CcSEcCtD
Levofloxacin—Thrombocytopenia—Betamethasone—ulcerative colitis	3.44e-05	0.000236	CcSEcCtD
Levofloxacin—Nausea—Mesalazine—ulcerative colitis	3.44e-05	0.000236	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.43e-05	0.00121	CbGpPWpGaD
Levofloxacin—Tachycardia—Dexamethasone—ulcerative colitis	3.43e-05	0.000235	CcSEcCtD
Levofloxacin—Tachycardia—Betamethasone—ulcerative colitis	3.43e-05	0.000235	CcSEcCtD
Levofloxacin—Angioedema—Prednisone—ulcerative colitis	3.43e-05	0.000235	CcSEcCtD
Levofloxacin—Dyspepsia—Triamcinolone—ulcerative colitis	3.41e-05	0.000234	CcSEcCtD
Levofloxacin—Dyspepsia—Methylprednisolone—ulcerative colitis	3.4e-05	0.000233	CcSEcCtD
Levofloxacin—Hyperhidrosis—Dexamethasone—ulcerative colitis	3.4e-05	0.000233	CcSEcCtD
Levofloxacin—Hyperhidrosis—Betamethasone—ulcerative colitis	3.4e-05	0.000233	CcSEcCtD
Levofloxacin—Feeling abnormal—Hydrocortisone—ulcerative colitis	3.39e-05	0.000232	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	3.38e-05	0.00119	CbGpPWpGaD
Levofloxacin—Malaise—Prednisone—ulcerative colitis	3.38e-05	0.000232	CcSEcCtD
Levofloxacin—Vertigo—Prednisone—ulcerative colitis	3.37e-05	0.000231	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	3.37e-05	0.000231	CcSEcCtD
Levofloxacin—Syncope—Prednisone—ulcerative colitis	3.36e-05	0.000231	CcSEcCtD
Levofloxacin—Anorexia—Betamethasone—ulcerative colitis	3.35e-05	0.00023	CcSEcCtD
Levofloxacin—Anorexia—Dexamethasone—ulcerative colitis	3.35e-05	0.00023	CcSEcCtD
Levofloxacin—Urticaria—Prednisolone—ulcerative colitis	3.35e-05	0.000229	CcSEcCtD
Levofloxacin—Fatigue—Triamcinolone—ulcerative colitis	3.34e-05	0.000229	CcSEcCtD
Levofloxacin—Fatigue—Methylprednisolone—ulcerative colitis	3.33e-05	0.000228	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—CHP1—ulcerative colitis	3.33e-05	0.00117	CbGpPWpGaD
Levofloxacin—Pain—Triamcinolone—ulcerative colitis	3.31e-05	0.000227	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	3.31e-05	0.00116	CbGpPWpGaD
Levofloxacin—Loss of consciousness—Prednisone—ulcerative colitis	3.3e-05	0.000226	CcSEcCtD
Levofloxacin—Hypotension—Betamethasone—ulcerative colitis	3.29e-05	0.000225	CcSEcCtD
Levofloxacin—Hypotension—Dexamethasone—ulcerative colitis	3.29e-05	0.000225	CcSEcCtD
Levofloxacin—Urticaria—Hydrocortisone—ulcerative colitis	3.27e-05	0.000224	CcSEcCtD
Levofloxacin—Body temperature increased—Hydrocortisone—ulcerative colitis	3.25e-05	0.000223	CcSEcCtD
Levofloxacin—Abdominal pain—Hydrocortisone—ulcerative colitis	3.25e-05	0.000223	CcSEcCtD
Levofloxacin—Hypertension—Prednisone—ulcerative colitis	3.24e-05	0.000222	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.21e-05	0.00113	CbGpPWpGaD
Levofloxacin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.2e-05	0.000219	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.2e-05	0.000219	CcSEcCtD
Levofloxacin—Arthralgia—Prednisone—ulcerative colitis	3.19e-05	0.000219	CcSEcCtD
Levofloxacin—Myalgia—Prednisone—ulcerative colitis	3.19e-05	0.000219	CcSEcCtD
Levofloxacin—Feeling abnormal—Triamcinolone—ulcerative colitis	3.19e-05	0.000219	CcSEcCtD
Levofloxacin—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.19e-05	0.000218	CcSEcCtD
Levofloxacin—Anxiety—Prednisone—ulcerative colitis	3.18e-05	0.000218	CcSEcCtD
Levofloxacin—Insomnia—Betamethasone—ulcerative colitis	3.18e-05	0.000218	CcSEcCtD
Levofloxacin—Insomnia—Dexamethasone—ulcerative colitis	3.18e-05	0.000218	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.17e-05	0.000217	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	3.17e-05	0.00111	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	3.17e-05	0.00111	CbGpPWpGaD
Levofloxacin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.16e-05	0.000217	CcSEcCtD
Levofloxacin—Paraesthesia—Dexamethasone—ulcerative colitis	3.16e-05	0.000216	CcSEcCtD
Levofloxacin—Paraesthesia—Betamethasone—ulcerative colitis	3.16e-05	0.000216	CcSEcCtD
Levofloxacin—Discomfort—Prednisone—ulcerative colitis	3.16e-05	0.000216	CcSEcCtD
Levofloxacin—Hypersensitivity—Prednisolone—ulcerative colitis	3.1e-05	0.000213	CcSEcCtD
Levofloxacin—Dyspepsia—Betamethasone—ulcerative colitis	3.09e-05	0.000212	CcSEcCtD
Levofloxacin—Dyspepsia—Dexamethasone—ulcerative colitis	3.09e-05	0.000212	CcSEcCtD
Levofloxacin—Urticaria—Triamcinolone—ulcerative colitis	3.08e-05	0.000211	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	3.07e-05	0.00108	CbGpPWpGaD
Levofloxacin—Urticaria—Methylprednisolone—ulcerative colitis	3.07e-05	0.00021	CcSEcCtD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—ulcerative colitis	3.07e-05	0.00108	CbGpPWpGaD
Levofloxacin—Body temperature increased—Triamcinolone—ulcerative colitis	3.06e-05	0.00021	CcSEcCtD
Levofloxacin—Oedema—Prednisone—ulcerative colitis	3.06e-05	0.00021	CcSEcCtD
Levofloxacin—Anaphylactic shock—Prednisone—ulcerative colitis	3.06e-05	0.00021	CcSEcCtD
Levofloxacin—Abdominal pain—Methylprednisolone—ulcerative colitis	3.06e-05	0.000209	CcSEcCtD
Levofloxacin—Decreased appetite—Betamethasone—ulcerative colitis	3.06e-05	0.000209	CcSEcCtD
Levofloxacin—Decreased appetite—Dexamethasone—ulcerative colitis	3.06e-05	0.000209	CcSEcCtD
Levofloxacin—Infection—Prednisone—ulcerative colitis	3.04e-05	0.000208	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.04e-05	0.000208	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.04e-05	0.000208	CcSEcCtD
Levofloxacin—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.03e-05	0.000208	CcSEcCtD
Levofloxacin—Fatigue—Dexamethasone—ulcerative colitis	3.03e-05	0.000208	CcSEcCtD
Levofloxacin—Fatigue—Betamethasone—ulcerative colitis	3.03e-05	0.000208	CcSEcCtD
Levofloxacin—Shock—Prednisone—ulcerative colitis	3.01e-05	0.000206	CcSEcCtD
Levofloxacin—Pain—Betamethasone—ulcerative colitis	3.01e-05	0.000206	CcSEcCtD
Levofloxacin—Pain—Dexamethasone—ulcerative colitis	3.01e-05	0.000206	CcSEcCtD
Levofloxacin—Nervous system disorder—Prednisone—ulcerative colitis	3e-05	0.000206	CcSEcCtD
Levofloxacin—Tachycardia—Prednisone—ulcerative colitis	2.99e-05	0.000205	CcSEcCtD
Levofloxacin—Skin disorder—Prednisone—ulcerative colitis	2.97e-05	0.000204	CcSEcCtD
Levofloxacin—Hyperhidrosis—Prednisone—ulcerative colitis	2.96e-05	0.000203	CcSEcCtD
Levofloxacin—Asthenia—Hydrocortisone—ulcerative colitis	2.95e-05	0.000202	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	2.95e-05	0.00104	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL2—ulcerative colitis	2.94e-05	0.00103	CbGpPWpGaD
Levofloxacin—Anorexia—Prednisone—ulcerative colitis	2.92e-05	0.0002	CcSEcCtD
Levofloxacin—Pruritus—Hydrocortisone—ulcerative colitis	2.91e-05	0.0002	CcSEcCtD
Levofloxacin—Feeling abnormal—Betamethasone—ulcerative colitis	2.9e-05	0.000199	CcSEcCtD
Levofloxacin—Feeling abnormal—Dexamethasone—ulcerative colitis	2.9e-05	0.000199	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	2.87e-05	0.000197	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Betamethasone—ulcerative colitis	2.87e-05	0.000197	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—DLD—ulcerative colitis	2.87e-05	0.00101	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Triamcinolone—ulcerative colitis	2.85e-05	0.000196	CcSEcCtD
Levofloxacin—Hypersensitivity—Methylprednisolone—ulcerative colitis	2.85e-05	0.000195	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.83e-05	0.000993	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	2.82e-05	0.00099	CbGpPWpGaD
Levofloxacin—Diarrhoea—Hydrocortisone—ulcerative colitis	2.82e-05	0.000193	CcSEcCtD
Levofloxacin—Urticaria—Dexamethasone—ulcerative colitis	2.79e-05	0.000191	CcSEcCtD
Levofloxacin—Urticaria—Betamethasone—ulcerative colitis	2.79e-05	0.000191	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	2.79e-05	0.000191	CcSEcCtD
Levofloxacin—Dizziness—Prednisolone—ulcerative colitis	2.79e-05	0.000191	CcSEcCtD
Levofloxacin—Asthenia—Triamcinolone—ulcerative colitis	2.78e-05	0.000191	CcSEcCtD
Levofloxacin—Abdominal pain—Dexamethasone—ulcerative colitis	2.78e-05	0.00019	CcSEcCtD
Levofloxacin—Body temperature increased—Betamethasone—ulcerative colitis	2.78e-05	0.00019	CcSEcCtD
Levofloxacin—Body temperature increased—Dexamethasone—ulcerative colitis	2.78e-05	0.00019	CcSEcCtD
Levofloxacin—Abdominal pain—Betamethasone—ulcerative colitis	2.78e-05	0.00019	CcSEcCtD
Levofloxacin—Asthenia—Methylprednisolone—ulcerative colitis	2.77e-05	0.00019	CcSEcCtD
Levofloxacin—Insomnia—Prednisone—ulcerative colitis	2.77e-05	0.00019	CcSEcCtD
Levofloxacin—Paraesthesia—Prednisone—ulcerative colitis	2.75e-05	0.000188	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.75e-05	0.000965	CbGpPWpGaD
Levofloxacin—Pruritus—Triamcinolone—ulcerative colitis	2.74e-05	0.000188	CcSEcCtD
Levofloxacin—Pruritus—Methylprednisolone—ulcerative colitis	2.74e-05	0.000187	CcSEcCtD
Levofloxacin—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	2.73e-05	0.000961	CbGpPWpGaD
Levofloxacin—Dizziness—Hydrocortisone—ulcerative colitis	2.72e-05	0.000186	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—ulcerative colitis	2.71e-05	0.000953	CbGpPWpGaD
Levofloxacin—Dyspepsia—Prednisone—ulcerative colitis	2.7e-05	0.000185	CcSEcCtD
Levofloxacin—Decreased appetite—Prednisone—ulcerative colitis	2.66e-05	0.000182	CcSEcCtD
Levofloxacin—Rash—Prednisolone—ulcerative colitis	2.66e-05	0.000182	CcSEcCtD
Levofloxacin—Dermatitis—Prednisolone—ulcerative colitis	2.65e-05	0.000182	CcSEcCtD
Levofloxacin—Diarrhoea—Methylprednisolone—ulcerative colitis	2.65e-05	0.000181	CcSEcCtD
Levofloxacin—Fatigue—Prednisone—ulcerative colitis	2.64e-05	0.000181	CcSEcCtD
Levofloxacin—Headache—Prednisolone—ulcerative colitis	2.64e-05	0.000181	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.63e-05	0.000925	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	2.63e-05	0.000925	CbGpPWpGaD
Levofloxacin—Constipation—Prednisone—ulcerative colitis	2.62e-05	0.000179	CcSEcCtD
Levofloxacin—Vomiting—Hydrocortisone—ulcerative colitis	2.62e-05	0.000179	CcSEcCtD
Levofloxacin—Rash—Hydrocortisone—ulcerative colitis	2.59e-05	0.000178	CcSEcCtD
Levofloxacin—Dermatitis—Hydrocortisone—ulcerative colitis	2.59e-05	0.000178	CcSEcCtD
Levofloxacin—Headache—Hydrocortisone—ulcerative colitis	2.58e-05	0.000177	CcSEcCtD
Levofloxacin—Dizziness—Triamcinolone—ulcerative colitis	2.56e-05	0.000176	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	2.56e-05	0.000898	CbGpPWpGaD
Levofloxacin—Dizziness—Methylprednisolone—ulcerative colitis	2.56e-05	0.000175	CcSEcCtD
Levofloxacin—Feeling abnormal—Prednisone—ulcerative colitis	2.52e-05	0.000173	CcSEcCtD
Levofloxacin—Asthenia—Dexamethasone—ulcerative colitis	2.52e-05	0.000173	CcSEcCtD
Levofloxacin—Asthenia—Betamethasone—ulcerative colitis	2.52e-05	0.000173	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Prednisone—ulcerative colitis	2.5e-05	0.000172	CcSEcCtD
Levofloxacin—Nausea—Prednisolone—ulcerative colitis	2.5e-05	0.000172	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.49e-05	0.000875	CbGpPWpGaD
Levofloxacin—Pruritus—Dexamethasone—ulcerative colitis	2.49e-05	0.00017	CcSEcCtD
Levofloxacin—Pruritus—Betamethasone—ulcerative colitis	2.49e-05	0.00017	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—IL6—ulcerative colitis	2.48e-05	0.000873	CbGpPWpGaD
Levofloxacin—Vomiting—Triamcinolone—ulcerative colitis	2.46e-05	0.000169	CcSEcCtD
Levofloxacin—Vomiting—Methylprednisolone—ulcerative colitis	2.46e-05	0.000168	CcSEcCtD
Levofloxacin—Nausea—Hydrocortisone—ulcerative colitis	2.44e-05	0.000167	CcSEcCtD
Levofloxacin—Rash—Triamcinolone—ulcerative colitis	2.44e-05	0.000167	CcSEcCtD
Levofloxacin—Dermatitis—Triamcinolone—ulcerative colitis	2.44e-05	0.000167	CcSEcCtD
Levofloxacin—Rash—Methylprednisolone—ulcerative colitis	2.44e-05	0.000167	CcSEcCtD
Levofloxacin—Dermatitis—Methylprednisolone—ulcerative colitis	2.44e-05	0.000167	CcSEcCtD
Levofloxacin—Urticaria—Prednisone—ulcerative colitis	2.43e-05	0.000167	CcSEcCtD
Levofloxacin—Headache—Triamcinolone—ulcerative colitis	2.43e-05	0.000166	CcSEcCtD
Levofloxacin—Headache—Methylprednisolone—ulcerative colitis	2.42e-05	0.000166	CcSEcCtD
Levofloxacin—Abdominal pain—Prednisone—ulcerative colitis	2.42e-05	0.000166	CcSEcCtD
Levofloxacin—Body temperature increased—Prednisone—ulcerative colitis	2.42e-05	0.000166	CcSEcCtD
Levofloxacin—Diarrhoea—Dexamethasone—ulcerative colitis	2.41e-05	0.000165	CcSEcCtD
Levofloxacin—Diarrhoea—Betamethasone—ulcerative colitis	2.41e-05	0.000165	CcSEcCtD
Levofloxacin—Dizziness—Dexamethasone—ulcerative colitis	2.32e-05	0.000159	CcSEcCtD
Levofloxacin—Dizziness—Betamethasone—ulcerative colitis	2.32e-05	0.000159	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.32e-05	0.000816	CbGpPWpGaD
Levofloxacin—Nausea—Triamcinolone—ulcerative colitis	2.3e-05	0.000158	CcSEcCtD
Levofloxacin—Nausea—Methylprednisolone—ulcerative colitis	2.3e-05	0.000157	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.29e-05	0.000805	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Prednisone—ulcerative colitis	2.26e-05	0.000155	CcSEcCtD
Levofloxacin—Vomiting—Dexamethasone—ulcerative colitis	2.24e-05	0.000153	CcSEcCtD
Levofloxacin—Vomiting—Betamethasone—ulcerative colitis	2.24e-05	0.000153	CcSEcCtD
Levofloxacin—Rash—Betamethasone—ulcerative colitis	2.22e-05	0.000152	CcSEcCtD
Levofloxacin—Rash—Dexamethasone—ulcerative colitis	2.22e-05	0.000152	CcSEcCtD
Levofloxacin—Dermatitis—Betamethasone—ulcerative colitis	2.21e-05	0.000152	CcSEcCtD
Levofloxacin—Dermatitis—Dexamethasone—ulcerative colitis	2.21e-05	0.000152	CcSEcCtD
Levofloxacin—Headache—Betamethasone—ulcerative colitis	2.2e-05	0.000151	CcSEcCtD
Levofloxacin—Headache—Dexamethasone—ulcerative colitis	2.2e-05	0.000151	CcSEcCtD
Levofloxacin—Asthenia—Prednisone—ulcerative colitis	2.2e-05	0.000151	CcSEcCtD
Levofloxacin—Pruritus—Prednisone—ulcerative colitis	2.17e-05	0.000148	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.14e-05	0.000752	CbGpPWpGaD
Levofloxacin—Diarrhoea—Prednisone—ulcerative colitis	2.09e-05	0.000144	CcSEcCtD
Levofloxacin—Nausea—Dexamethasone—ulcerative colitis	2.09e-05	0.000143	CcSEcCtD
Levofloxacin—Nausea—Betamethasone—ulcerative colitis	2.09e-05	0.000143	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.08e-05	0.00073	CbGpPWpGaD
Levofloxacin—Dizziness—Prednisone—ulcerative colitis	2.02e-05	0.000139	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.97e-05	0.000693	CbGpPWpGaD
Levofloxacin—Vomiting—Prednisone—ulcerative colitis	1.95e-05	0.000133	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.94e-05	0.000681	CbGpPWpGaD
Levofloxacin—Rash—Prednisone—ulcerative colitis	1.93e-05	0.000132	CcSEcCtD
Levofloxacin—Dermatitis—Prednisone—ulcerative colitis	1.93e-05	0.000132	CcSEcCtD
Levofloxacin—Headache—Prednisone—ulcerative colitis	1.92e-05	0.000131	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—CHP1—ulcerative colitis	1.82e-05	0.000639	CbGpPWpGaD
Levofloxacin—Nausea—Prednisone—ulcerative colitis	1.82e-05	0.000125	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—DLD—ulcerative colitis	1.57e-05	0.000552	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.56e-05	0.000549	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.56e-05	0.000548	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.45e-05	0.00051	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS1—ulcerative colitis	1.39e-05	0.000488	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.36e-05	0.000478	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.36e-05	0.000477	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.3e-05	0.000456	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—DLD—ulcerative colitis	1.25e-05	0.00044	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CALM3—ulcerative colitis	1.25e-05	0.000439	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—ulcerative colitis	1.22e-05	0.00043	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.13e-05	0.000397	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.12e-05	0.000394	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.06e-05	0.000372	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.06e-05	0.000371	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCB1—ulcerative colitis	9.73e-06	0.000342	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—DLD—ulcerative colitis	9.67e-06	0.00034	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	9.31e-06	0.000327	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ADCY5—ulcerative colitis	9.08e-06	0.000319	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS1—ulcerative colitis	7.59e-06	0.000267	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.1e-06	0.000249	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CALM3—ulcerative colitis	6.83e-06	0.00024	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PPARG—ulcerative colitis	6.77e-06	0.000238	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.63e-06	0.000233	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALB—ulcerative colitis	6.09e-06	0.000214	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS1—ulcerative colitis	6.06e-06	0.000213	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.96e-06	0.000209	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CALM3—ulcerative colitis	5.46e-06	0.000192	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS2—ulcerative colitis	5.32e-06	0.000187	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.21e-06	0.000183	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADCY5—ulcerative colitis	4.96e-06	0.000174	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4.68e-06	0.000164	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCB1—ulcerative colitis	4.24e-06	0.000149	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CALM3—ulcerative colitis	4.21e-06	0.000148	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.96e-06	0.000139	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PPARG—ulcerative colitis	3.7e-06	0.00013	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALB—ulcerative colitis	3.32e-06	0.000117	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCB1—ulcerative colitis	3.27e-06	0.000115	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADCY5—ulcerative colitis	3.05e-06	0.000107	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.95e-06	0.000104	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.91e-06	0.000102	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALB—ulcerative colitis	2.65e-06	9.32e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS2—ulcerative colitis	2.32e-06	8.16e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.28e-06	8e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALB—ulcerative colitis	2.05e-06	7.2e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.79e-06	6.3e-05	CbGpPWpGaD
